Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,128,224
+$1,163,953 QoQ
Shares Held
256,104
+181.5% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 198 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. ARVN ranks #58 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in ARVN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,128,224 | 256,104 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $964,271 | 90,969 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,184,647 | 99,886 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $437,425 | 51,341 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $395,585 | 53,748 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $477,977 | 68,088 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $249,969 | 10,149 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $1,032,337 | 52,563 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $1,271,503 | 51,229 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,092,390 | 39,985 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $3,286,519 | 96,069 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,417,063 | 211,667 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,138,142 | 193,351 | Principal | Defined | 2022-08-15 | |
| 2021-12-31 | $229,663 | 2,796 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $446,647 | 5,435 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $466,235 | 6,055 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $363,483 | 5,499 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,885,446 | 22,200 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $609,138 | 25,800 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,373,074 | 160,199 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||